Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Molecular and Cellular Endocrinology|July 17, 2007
Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic indexHeike Schäcke, Markus Berger, Hartmut Rehwinkel, et al.European Cytokine Network|June 9, 2005
Cytokines as potential therapeutic targets for inflammatory skin diseasesRobert P Numerof, Charles A Dinarello, Khusru AsadullahExperimental Dermatology|May 13, 2006
Glucocorticoid therapy-induced skin atrophyStefanie Schoepe, Heike Schäcke, Ekkehard May, et al.Expert Opinion on Biological Therapy|July 26, 2003
Cytokine and anticytokine therapy in dermatologyUwe Trefzer, Maja Hofmann, Wolfram Sterry, et al.The Journal of Investigative Dermatology|December 18, 2002
A novel immunosuppressive 1alpha,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activityUlrich Zügel, Andreas Steinmeyer, Claudia Giesen, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Cutting edge: immune cells as sources and targets of the IL-10 family members?Kerstin Wolk, Stefanie Kunz, Khusru Asadullah, et al.Drug Discovery Today|September 28, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.Archivum Immunologiae Et Therapiae Experimentalis|January 28, 2003
Experimental therapies for psoriasisKhusru Asadullah, Hans-Dieter Volk, Markus Friedrich, et al.Current Drug Targets. Inflammation and Allergy|December 9, 2004
The glucocorticoid receptor as target for classic and novel anti-inflammatory therapyAndrew C B Cato, Heike Schäcke, Wolfram Sterry, et al.The Journal of Investigative Dermatology|August 7, 2009
The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammationArndt J Schottelius, Ulrich Zügel, Wolf-Dietrich Döcke, et al.Pageof 12